• Sign In
  • Sign Out
  • My Account
Subscribe
  • BioWorld
  • BioWorld MedTech
  • BioWorld Asia
  • BioWorld Science
  • Data Snapshots
  • Special reports
Clarivate
  • Data Snapshots
  • BioWorld
  • BioWorld MedTech
  • Infographics: Dynamic digital data analysis
  • Index insights
  • Special reports
  • Infographics: Dynamic digital data analysis
  • Trump administration impacts
  • Biopharma M&A scorecard
  • BioWorld 2024 review
  • BioWorld MedTech 2024 review
  • BioWorld Science 2024 review
  • Women's health
  • China's GLP-1 landscape
  • PFA re-energizes afib market
  • China CAR T
  • Alzheimer's disease
  • Coronavirus
  • More reports can be found here

BioWorld. Link to homepage.

Clarivate
  • BioWorld
  • BioWorld MedTech
  • BioWorld Asia
  • BioWorld Science
  • Data Snapshots
    • BioWorld
    • BioWorld MedTech
    • Infographics: Dynamic digital data analysis
    • Index insights
  • Special reports
    • Infographics: Dynamic digital data analysis
    • Trump administration impacts
    • Biopharma M&A scorecard
    • BioWorld 2024 review
    • BioWorld MedTech 2024 review
    • BioWorld Science 2024 review
    • Women's health
    • China's GLP-1 landscape
    • PFA re-energizes afib market
    • China CAR T
    • Alzheimer's disease
    • Coronavirus
    • More reports can be found here

BioWorld. Link to homepage.

  • Sign In
  • Sign Out
  • My Account
Subscribe
Home » Authors » Lynn Yoffee

Articles by Lynn Yoffee

Inovio Biomedical miniaturizes vaccine electroporation device

Feb. 1, 2010
By Lynn Yoffee
Just a little zap and temporary pores open. Inovio Biomedical (San Diego) is banking on this process, known as electroporation, to substantially change vaccine delivery. It has just unveiled a new clinical-grade, miniaturized device designed to deliver a variety of DNA vaccines, opening the door to push its healthy pipeline of new-style preventive and therapeutic vaccines into human trials. (Medical Device Daily)
Read More

Halt's fibroid device, procedure to make other treatments 'irrelevant'

Jan. 28, 2010
By Lynn Yoffee

IBM tech finds brain aneurysms better than manual approach

Jan. 27, 2010
By Lynn Yoffee
The computerized "eye" is better than any human eye. That theory has been proven positive when it comes to spotting brain aneurysms. An IBM (Armonk, New York) and Mayo Clinic (Rochester, New York) alliance has yielded analytics technology with a 95% accuracy rate in detecting aneurysms, compared with a 70% rate for standard manual interpretation. (Medical Device Daily)
Read More

Rocking embryos via microfluidic device improves IVF success

Jan. 22, 2010
By Lynn Yoffee

Lantheus Medical launches first imaging agent for use with MRA

Jan. 21, 2010
By Lynn Yoffee

Study: Oncotype DX is changing breast cancer treatment choices

Jan. 18, 2010
By Lynn Yoffee

MarginProbe aims to reduce breast cancer reoperations

Jan. 15, 2010
By Lynn Yoffee

First hand-held OCT device IDs blinding condition in preemies

Jan. 14, 2010
By Lynn Yoffee

Philips launches enhanced BiPAP for complicated form of sleep apnea

Jan. 11, 2010
By Lynn Yoffee
For up to 10% of people with sleep disordered breathing, standard CPAP machines won't do the trick. Royal Philips Electronics (Murrysville, Pennsylvania) has launched a new, enhanced version BiPAP autoSV Advanced for patients who have both obstructive sleep apnea and central sleep apnea as well as Cheyne-Stokes Respiration, a periodic breathing disorder. (Medical Device Daily)
Read More

TORS dramatically changes head, neck cancer outcomes

Jan. 8, 2010
By Lynn Yoffee
Previous 1 2 … 6 7 8 9 10 11 12 13 14 … 50 51 Next

Popular Stories

  • Today's news in brief

    BioWorld
    BioWorld briefs for July 8, 2025.
  • Today's news in brief

    BioWorld MedTech
    BioWorld MedTech briefs for July 8, 2025.
  • Kidney disease illustration

    Prokidney produces positive phase II CKD data, thunderous stock surge

    BioWorld
    A mixed bag of top-line phase II data prompted stellar stock results for Prokidney Corp. and its chronic kidney disease (CKD) and diabetes therapy, rilparencel....
  • Illustration of the β2-adrenergic receptor

    Exercise-mimicking compound offers alternative to GLP-1 therapies

    BioWorld
    An experimental drug for treating diabetes and obesity has been shown to lower blood sugar levels and increase fat burning. It is a β2-adrenergic receptor (β2AR)...
  • News in brief

    BioWorld Asia
    BioWorld Asia briefs for July 8, 2025
  • BioWorld
    • Today's news
    • Analysis and data insight
    • Clinical
    • Data Snapshots
    • Deals and M&A
    • Financings
    • Newco news
    • Opinion
    • Regulatory
    • Science
  • BioWorld MedTech
    • Today's news
    • Clinical
    • Data Snapshots
    • Deals and M&A
    • Financings
    • Newco news
    • Opinion
    • Regulatory
    • Science
  • BioWorld Asia
    • Today's news
    • Analysis and data insight
    • Australia
    • China
    • Clinical
    • Deals and M&A
    • Financings
    • Newco news
    • Regulatory
    • Science
  • BioWorld Science
    • Today's news
    • Biomarkers
    • Cancer
    • Conferences
    • Endocrine/Metabolic
    • Immune
    • Infection
    • Neurology/Psychiatric
    • Patents
  • More
    • About
    • Advertise with BioWorld
    • Archives
    • Article reprints and permissions
    • Contact us
    • Cookie policy
    • Copyright notice
    • Data methodology
    • Infographics: Dynamic digital data analysis
    • Index insights
    • Podcasts
    • Privacy policy
    • Share your news with BioWorld
    • Staff
    • Terms of use
    • Topic alerts
Follow Us

Copyright ©2025. All Rights Reserved. Design, CMS, Hosting & Web Development :: ePublishing

BioWorld. Link to homepage.

Clarivate
  • BioWorld
  • BioWorld MedTech
  • BioWorld Asia
  • BioWorld Science
  • Data Snapshots
    • BioWorld
    • BioWorld MedTech
    • Infographics: Dynamic digital data analysis
    • Index insights
  • Special reports
    • Infographics: Dynamic digital data analysis
    • Trump administration impacts
    • Biopharma M&A scorecard
    • BioWorld 2024 review
    • BioWorld MedTech 2024 review
    • BioWorld Science 2024 review
    • Women's health
    • China's GLP-1 landscape
    • PFA re-energizes afib market
    • China CAR T
    • Alzheimer's disease
    • Coronavirus
    • More reports can be found here

BioWorld. Link to homepage.

  • Sign In
  • Sign Out
  • My Account
Subscribe